Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled Clinical Trial

Our findings suggest that sequential infusion of MSCs within 3 months after haplo-HSCT significantly reduced both the incidence and severity of cGVHD and aGVHD, manifesting as a better GRFS rate for patients.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-04-15
DOI
https://doi.org/10.1200/jco-24-02119
Citations
10
Primary Topic
Mesenchymal stem cell research
Type
article
Field-Weighted Citation Impact
16.25
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled Clinical Trial

Ruihao Huang, Ren Lin, Qifa Liu, Xiao‐Jun Huang et al.
10 citations
Journal of Clinical Oncology
Mesenchymal stem cell research
16.25
article

Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled Clinical Trial

Ruihao Huang, Ren Lin, Qifa Liu, Xiao‐Jun Huang, Haixia Fu, Li Gao, Yimei Feng, Lu Zhao, Lidan Zhu, Xiaoqi Wang, Lu Wang, Jia Liu, Xi Zhang, Ting Chen, Yanqi Zhang, Yuqing Liu, Wen Qin, Han Yao, Lei Gao, Xiaohui Zhang, Peiyan Kong, Cheng Zhang, Yu Wang
article en
10 citations

Abstract

Our findings suggest that sequential infusion of MSCs within 3 months after haplo-HSCT significantly reduced both the incidence and severity of cGVHD and aGVHD, manifesting as a better GRFS rate for patients.

Journal of Clinical OncologyVol. 43(17)
Army Medical University (CN), Peking University (CN), Nanfang Hospital (CN), Xinqiao Hospital (CN), Peking University People's Hospital (CN), Southern Medical University (CN)
Good health and well-being
Openalex Percentile: Top 1%
Mesenchymal stem cell research
16.25
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.